Quaglio G, Lugoboni F, Fornasiero A, Lechi A, Gerra G, Mezzelani P. Dependence on zolpidem: two case reports of detoxification with flumazenil infusion. International Clinical Psychopharmacology. September 2005, 20 (5): 285–7. PMID 16096519. doi:10.1097/01.yic.0000166404.41850.b4.
Treves N, Perlman A, Kolenberg Geron L, Asaly A, Matok I. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis. Age and Ageing. March 2018, 47 (2): 201–208. PMID 29077902. doi:10.1093/ageing/afx167.
American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. July 2023, 71 (7): 2052–2081. doi:10.1111/jgs.18372.
Fontaine R, Beaudry P, Le Morvan P, Beauclair L, Chouinard G. Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. International Clinical Psychopharmacology. July 1990, 5 (3): 173–83. PMID 2230061. doi:10.1097/00004850-199007000-00002.
Stone JR, Zorick TS, Tsuang J. Dose-related illusions and hallucinations with zaleplon. Clinical Toxicology. April 2008, 46 (4): 344–5. PMID 17852167. doi:10.1080/15563650701517442.
Toner LC, Tsambiras BM, Catalano G, Catalano MC, Cooper DS. Central nervous system side effects associated with zolpidem treatment. Clinical Neuropharmacology. 2000, 23 (1): 54–8. PMID 10682233. doi:10.1097/00002826-200001000-00011.
Yang W, Dollear M, Muthukrishnan SR. One rare side effect of zolpidem--sleepwalking: a case report. Archives of Physical Medicine and Rehabilitation. June 2005, 86 (6): 1265–6. PMID 15954071. doi:10.1016/j.apmr.2004.11.022.
Liskow B, Pikalov A. Zaleplon overdose associated with sleepwalking and complex behavior. Journal of the American Academy of Child and Adolescent Psychiatry. August 2004, 43 (8): 927–8. PMID 15266187. doi:10.1097/01.chi.0000129219.66563.aa.
Torres-Bondia, F; Dakterzada, F; Galván, L; Buti, M; Besanson, G; Grill, E; Buil, R; de Batlle, J; Piñol-Ripoll, G. Benzodiazepine and Z-Drug Use and the Risk of Developing Dementia.. The international journal of neuropsychopharmacology. 2022-04-19, 25 (4): 261–268. PMID 34727174. doi:10.1093/ijnp/pyab073.
Quaglio G, Lugoboni F, Fornasiero A, Lechi A, Gerra G, Mezzelani P. Dependence on zolpidem: two case reports of detoxification with flumazenil infusion. International Clinical Psychopharmacology. September 2005, 20 (5): 285–7. PMID 16096519. doi:10.1097/01.yic.0000166404.41850.b4.
Treves N, Perlman A, Kolenberg Geron L, Asaly A, Matok I. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis. Age and Ageing. March 2018, 47 (2): 201–208. PMID 29077902. doi:10.1093/ageing/afx167.
Fontaine R, Beaudry P, Le Morvan P, Beauclair L, Chouinard G. Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. International Clinical Psychopharmacology. July 1990, 5 (3): 173–83. PMID 2230061. doi:10.1097/00004850-199007000-00002.
Stone JR, Zorick TS, Tsuang J. Dose-related illusions and hallucinations with zaleplon. Clinical Toxicology. April 2008, 46 (4): 344–5. PMID 17852167. doi:10.1080/15563650701517442.
Toner LC, Tsambiras BM, Catalano G, Catalano MC, Cooper DS. Central nervous system side effects associated with zolpidem treatment. Clinical Neuropharmacology. 2000, 23 (1): 54–8. PMID 10682233. doi:10.1097/00002826-200001000-00011.
Yang W, Dollear M, Muthukrishnan SR. One rare side effect of zolpidem--sleepwalking: a case report. Archives of Physical Medicine and Rehabilitation. June 2005, 86 (6): 1265–6. PMID 15954071. doi:10.1016/j.apmr.2004.11.022.
Liskow B, Pikalov A. Zaleplon overdose associated with sleepwalking and complex behavior. Journal of the American Academy of Child and Adolescent Psychiatry. August 2004, 43 (8): 927–8. PMID 15266187. doi:10.1097/01.chi.0000129219.66563.aa.
Torres-Bondia, F; Dakterzada, F; Galván, L; Buti, M; Besanson, G; Grill, E; Buil, R; de Batlle, J; Piñol-Ripoll, G. Benzodiazepine and Z-Drug Use and the Risk of Developing Dementia.. The international journal of neuropsychopharmacology. 2022-04-19, 25 (4): 261–268. PMID 34727174. doi:10.1093/ijnp/pyab073.
Sivertsen, B; Omvik, S; Pallesen, S; Nordhus, IH; Bjorvatn, B. Sleep and sleep disorders in chronic users of zopiclone and drug-free insomniacs.. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2009-08-15, 5 (4): 349–54. PMID 19968013.